Mutant mouse models of insulin-like growth factor actions in the central nervous system.
about
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelinationRegulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon RegenerationNeurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegalyThe effects of induced type-I diabetes on developmental regulation of insulin & insulin like growth factor-1 (IGF-1) receptors in the cerebellum of rat neonatesSex differences and left-right asymmetries in expression of insulin and insulin-like growth factor-1 receptors in developing rat hippocampusInsulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of functionTranscriptomic analysis of the zebrafish inner ear points to growth hormone mediated regeneration following acoustic traumaA comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice.Genetic, physiologic and ecogeographic factors contributing to variation in Homo sapiens: Homo floresiensis reconsidered.Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampusAssociation of insulin-like growth factor-I with the severity and outcomes of acute ischemic stroke.Microstructural brain changes in acromegaly: quantitative analysis by diffusion tensor imaging.Insulin and IGF receptor signalling in neural-stem-cell homeostasis.Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected].Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats.IGF-1-induced enhancement of PRNP expression depends on the negative regulation of transcription factor FOXO3a.Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidenceThe role of insulin-like growth factor-I in the physiopathology of hearing.Insulin-like growth factor-I stimulates histone H3 and H4 acetylation in the brain in vivo.Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampusCombination treatment with ethyl pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathyIGF-1 in the brain as a regulator of reproductive neuroendocrine function.The effect of recombinant human growth hormone therapy in patients with completed stroke: a pilot trial.Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.Acute neuroprotective synergy of erythropoietin and insulin-like growth factor IInterplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.White matter damage after chronic subclinical inflammation in newborn mice.Rapid Eye Movement Sleep Deprivation Produces Long-Term Detrimental Effects in Spatial Memory and Modifies the Cellular Composition of the Subgranular ZoneExpanding the mind: insulin-like growth factor I and brain development.System consolidation of spatial memories in mice: effects of enriched environment.Somatotropic signaling: trade-offs between growth, reproductive development, and longevityEvaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study.The role of liver-derived insulin-like growth factor-I.Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment OptionsInsulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Neuroprotective Role of the PI3 Kinase/Akt Signaling Pathway in Zebrafish.TSC1/TSC2 signaling in the CNS.Signaling mechanisms regulating myelination in the central nervous system.
P2860
Q24310284-E1DF852A-03A1-4175-8946-C1CCBD240D56Q26745419-4E52CAE3-C5D5-421E-B121-F6E2A9696962Q28486006-D7C6C084-4738-40E0-A36E-22A8C7DA8F2AQ28571907-0C4CCA60-2A54-4723-BB3D-94FD39E0559AQ28577411-6128C80E-5C0A-487F-A004-50CFBFBBF2D1Q30468589-6720F172-A9BF-41FC-A342-E843C33AA1DEQ30474115-3F0E5611-5E82-404A-B9C6-6145653B0F64Q30495585-FDE1C697-375A-4657-A546-E410FE77CDCFQ31066777-1AEDABB8-296E-4D01-BD59-4F3FCF20E59EQ33282608-390D0694-D46E-43AF-B73A-C601ACBBD608Q33566257-6C25832D-273C-4E43-ABE9-1DF01C877B0EQ33823168-4C57F0E3-DDBD-41C6-B965-74CB412A90D6Q33911127-A3C9867F-B2CA-4BB6-9438-14D3D6E62CAFQ34007543-3D006AEB-321F-46AC-8446-F7EC990C9B77Q34517902-81746DC0-7B9E-472F-9906-77472858E8C7Q34610063-F32A5E28-250C-4AB3-B2E3-D705A0A511B3Q34964641-B7262158-6249-4BBA-A2CC-BAB0A2EE42E4Q35099084-24AD32C4-4A2B-4B7B-940C-5BC865BE4493Q35135142-A5F047F6-25AF-4DD6-B17F-3F403C7924DAQ35741650-0AB4E710-8C1D-4169-8910-A78C5A92C68AQ35780769-F31A863A-5727-4B53-8709-437B0788594FQ35827614-6FC6468C-1411-4C2B-908A-53BCC43D0A0EQ36108290-11E35610-8B99-4E19-8301-7E97D3700F84Q36223711-BDB6CC9F-17ED-43BE-A8E8-4E7976E00B78Q36410278-A6193702-E24E-4D10-988A-84DE3165CA3EQ36449204-1114B7CF-4CAC-4797-9E1D-74E268E4A334Q36678075-07792FD5-F2B8-4D30-BE55-862B1BC42DB8Q36907520-E65F1B40-A972-4FF0-A02F-C0054E95EA73Q36946060-EFD83E72-951B-4ABA-B09C-A1B0A73ABD96Q37034897-DA08DCCE-A7C3-4628-BCA7-80F4563EE207Q37045137-72C577E7-BE3E-4297-B007-38C8F3C372FBQ37158512-4559305E-026E-4B8C-9204-DEAAF6312A27Q37213531-B7CE750B-CDBA-4A91-903F-156E823CAE16Q37266733-CF6B6533-9F37-4FFE-810D-A30B80BE59F1Q37381848-8C9A9D58-B24B-450C-9400-3B0B869B0A48Q37383972-3BD34635-04CB-49C0-943F-E634715116A9Q37602608-A140F8C4-DEBB-4EE5-AA18-AB1BDB398793Q37629872-CF4D027A-D3B1-4EB7-A846-5CA406D9C97AQ37844199-CE2265DC-0CA2-4140-BFC8-171BFA150B14Q38096247-0B3997FC-421F-44AC-BED8-9DEB39BF591D
P2860
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@ast
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@en
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@nl
type
label
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@ast
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@en
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@nl
prefLabel
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@ast
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@en
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@nl
P2093
P356
P1433
P1476
Mutant mouse models of insulin-like growth factor actions in the central nervous system.
@en
P2093
A Joseph D'Ercole
John R O'Kusky
P304
P356
10.1054/NPEP.2002.0893
P577
2002-04-01T00:00:00Z